RESUMEN
AIMS: The aim of this study was to evaluate whether neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) predict outcome in heart failure (HF) patients undergoing heart transplantation (HTX). METHODS AND RESULTS: Data from 111 HF patients undergoing HTX 2010-2015 were retrospectively reviewed. NLR and PLR were calculated before HTX, immediately after HTX, and at 6 and 24 hours. Primary endpoint was in-hospital mortality, and secondary endpoints were 1 year mortality and renal replacement therapy (RRT). Prognostic factors were assessed by multivariate analysis, and the predictive values of NLR and PLR for mortality were compared. The discriminatory performance for predicting in-hospital mortality was better for NLR [area under the receiver operating characteristic curve (AUC) = 0.644, 95% confidence interval 0.492-0.797] than for PLR (AUC = 0.599, 95% confidence interval 0.423-0.776). Best cut-off value was 2.41 for NLR (sensitivity 86%, specificity 67%) and 92.5 for PLR (sensitivity 86%, specificity 68%). When divided according to best cut-off value, in-hospital mortality was significantly higher in the high NLR group (17.5% vs. 3.2%, P < 0.05), but not in the high PLR group (16.5% vs. 6.3%, P = ns). One year mortality was not significantly higher for either group (37.5% vs. 6.5% for NLR; 36.7% vs. 9.4% for PLR, P = ns for both), while RRT was significantly higher in both the NLR and PLR high groups (33.8% vs. 0%; 32.9% vs. 3.1%, respectively, P < 0.001). Multivariate analysis indicated that only high NLR (hazard ratio = 3.403, P < 0.05) and pre-transplant diabetes (hazard ratio = 3.364, P < 0.05) were independent prognostic factors for 1 year mortality. CONCLUSIONS: High NLR was a predictor for in-hospital mortality, and an independent prognostic factor for 1 year mortality. Both high NLR and high PLR were predictors for RRT.
Asunto(s)
Plaquetas/patología , Insuficiencia Cardíaca/cirugía , Trasplante de Corazón , Linfocitos/patología , Neutrófilos/patología , Argentina/epidemiología , Femenino , Insuficiencia Cardíaca/sangre , Insuficiencia Cardíaca/mortalidad , Mortalidad Hospitalaria/tendencias , Humanos , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Recuento de Plaquetas , Pronóstico , Curva ROC , Estudios Retrospectivos , Factores de Riesgo , Tasa de Supervivencia/tendenciasRESUMEN
RESUMEN Introducción: El anillo mitral calcificado es un proceso degenerativo que, de encontrarse presente en pacientes con indicación de tratamiento quirúrgico de la válvula mitral, implica un problema técnico de difícil resolución, que genera un aumento de probabilidad de complicaciones graves como accidente cerebrovascular, fugas perivalvulares, sangrado y muerte. Objetivo: El propósito del estudio es describir nuestra experiencia con cirugía valvular mitral en el contexto de calcificación grave del anillo mitral. Material y métodos: entre julio de 2010 y julio de 2020, 28 pacientes fueron intervenidos por patología valvular mitral en presencia de anillo mitral gravemente calcificado. La mediana de edad de la población fue de 77 años y el 68% fue de sexo femenino. Se realizó reemplazo valvular mitral en todos los casos asociado con reemplazo valvular aórtico en el 36%, con plástica tricuspídea en el 11% y con cirugía de revascularización miocárdica en el 21% de los casos. Resultados: Dos pacientes fallecieron en el hospital. Las complicaciones posoperatorias más frecuentes fueron la fibrilación auricular y la insuficiencia renal aguda. No se observaron fugas perivalvulares ni complicaciones asociadas con la prótesis. Conclusiones: La cirugía valvular mitral en presencia de anillo mitral calcificado puede realizarse con resultados aceptables para el perfil de riesgo de la población con la patología y de acuerdo con lo informado en publicaciones internacionales.
ABSTRACT Background: Mitral annulus calcification is a degenerative process which poses a challenging technical problem in patients undergoing surgical treatment of the mitral valve, increasing the probability of severe complications as stroke, perivalvular leaks, bleeding and death. Objective: The aim of this study was to describe our experience in mitral valve surgery with severe mitral annulus calcification. Methods: Between July 2010 and July 2020, 28 patients underwent surgery due to mitral valve disease with severe mitral annulus calcification. Median age was 77 years and 68% of patients were female. Mitral valve replacement was performed in all patients, associated with aortic valve replacement in 36%, tricuspid valve repair in 11% and coronary artery bypass graft surgery in 21% of cases. Results: Two patients died during hospitalization. The most frequent postoperative complications were atrial fibrillation and acute kidney failure. No perivalvular leaks or prosthesis-associated complications were observed. Conclusions: Mitral valve surgery in the presence of mitral annulus calcification can be performed with acceptable results for the risk profile of the population with the disease and according to international publications.